144 related articles for article (PubMed ID: 9551418)
1. Bicarbonate and bicarbonate/lactate peritoneal dialysis solutions for the treatment of infusion pain.
Mactier RA; Sprosen TS; Gokal R; Williams PF; Lindbergh M; Naik RB; Wrege U; Gröntoft KC; Larsson R; Berglund J; Tranaeus AP; Faict D
Kidney Int; 1998 Apr; 53(4):1061-7. PubMed ID: 9551418
[TBL] [Abstract][Full Text] [Related]
2. Improved acidosis correction and recovery of mesothelial cell mass with neutral-pH bicarbonate dialysis solution among children undergoing automated peritoneal dialysis.
Haas S; Schmitt CP; Arbeiter K; Bonzel KE; Fischbach M; John U; Pieper AK; Schaub TP; Passlick-Deetjen J; Mehls O; Schaefer F
J Am Soc Nephrol; 2003 Oct; 14(10):2632-8. PubMed ID: 14514742
[TBL] [Abstract][Full Text] [Related]
3. Clinical experience with two physiologic bicarbonate/lactate peritoneal dialysis solutions in automated peritoneal dialysis.
Dratwa M; Wilkie M; Ryckelynck JP; ter Wee PM; Rutherford P; Michel C; Hopwood A; Curtis L; Denys N; Divino Filho JC; Faict D;
Kidney Int Suppl; 2003 Dec; (88):S105-13. PubMed ID: 14870884
[TBL] [Abstract][Full Text] [Related]
4. Impact of new dialysis solutions on peritonitis rates.
Ahmad S; Sehmi JS; Ahmad-Zakhi KH; Clemenger M; Levy JB; Brown EA
Kidney Int Suppl; 2006 Nov; (103):S63-6. PubMed ID: 17080113
[TBL] [Abstract][Full Text] [Related]
5. A long-term study of a bicarbonate/lactate-based peritoneal dialysis solution--clinical benefits. The Bicarbonate/Lactate Study Group.
Tranaeus A
Perit Dial Int; 2000; 20(5):516-23. PubMed ID: 11117242
[TBL] [Abstract][Full Text] [Related]
6. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
[TBL] [Abstract][Full Text] [Related]
7. Biocompatibility pattern of a bicarbonate/lactate-buffered peritoneal dialysis fluid in APD: a prospective, randomized study.
Fusshoeller A; Plail M; Grabensee B; Plum J
Nephrol Dial Transplant; 2004 Aug; 19(8):2101-6. PubMed ID: 15213322
[TBL] [Abstract][Full Text] [Related]
8. BIOKID: randomized controlled trial comparing bicarbonate and lactate buffer in biocompatible peritoneal dialysis solutions in children [ISRCTN81137991].
Nau B; Schmitt CP; Almeida M; Arbeiter K; Ardissino G; Bonzel KE; Edefonti A; Fischbach M; Haluany K; Misselwitz J; Kemper MJ; Rönnholm K; Wygoda S; Schaefer F;
BMC Nephrol; 2004 Oct; 5():14. PubMed ID: 15485574
[TBL] [Abstract][Full Text] [Related]
9. The in vitro biocompatibility performance of a 25 mmol/L bicarbonate/10 mmol/L lactate-buffered peritoneal dialysis fluid.
Skoufos L; Topley N; Cooker L; Dawnay A; Millar DJ; Holmes CJ; Faict D
Kidney Int Suppl; 2003 Dec; (88):S94-9. PubMed ID: 14870882
[TBL] [Abstract][Full Text] [Related]
10. Volume control in peritoneal dialysis patients: role of new dialysis solutions.
Lameire N
Blood Purif; 2004; 22(1):44-54. PubMed ID: 14732811
[TBL] [Abstract][Full Text] [Related]
11. Better correction of metabolic acidosis, blood pressure control, and phagocytosis with bicarbonate compared to lactate solution in acute peritoneal dialysis.
Thongboonkerd V; Lumlertgul D; Supajatura V
Artif Organs; 2001 Feb; 25(2):99-108. PubMed ID: 11251475
[TBL] [Abstract][Full Text] [Related]
12. Short-term effects of bicarbonate/lactate-buffered and conventional lactate-buffered dialysis solutions on peritoneal ultrafiltration: a comparative crossover study.
Pajek J; Kveder R; Bren A; Gucek A; Bucar M; Skoberne A; Waniewski J; Lindholm B
Nephrol Dial Transplant; 2009 May; 24(5):1617-25. PubMed ID: 19066345
[TBL] [Abstract][Full Text] [Related]
13. Bicarbonate/lactate-based peritoneal dialysis solution increases cancer antigen 125 and decreases hyaluronic acid levels.
Jones S; Holmes CJ; Krediet RT; Mackenzie R; Faict D; Tranaeus A; Williams JD; Coles GA; Topley N;
Kidney Int; 2001 Apr; 59(4):1529-38. PubMed ID: 11260417
[TBL] [Abstract][Full Text] [Related]
14. Randomized long-term evaluation of bicarbonate-buffered CAPD solution.
Feriani M; Kirchgessner J; La Greca G; Passlick-Deetjen J
Kidney Int; 1998 Nov; 54(5):1731-8. PubMed ID: 9844152
[TBL] [Abstract][Full Text] [Related]
15. Bicarbonate: the alternative buffer for peritoneal dialysis.
Passlick-Deetjen J; Kirchgessner J
Perit Dial Int; 1996; 16 Suppl 1():S109-13. PubMed ID: 8728174
[TBL] [Abstract][Full Text] [Related]
16. Effect of bicarbonate/lactate peritoneal dialysis solutions on human mesothelial cell proliferation ex vivo.
Bajo MA; del Peso G; Castro MA; Díaz C; Castro MJ; Gil F; Sánchez-Tomero JA; Selgas R
Adv Perit Dial; 2001; 17():37-41. PubMed ID: 11510293
[TBL] [Abstract][Full Text] [Related]
17. Acid-base profile and predictors of metabolic acidosis in patients undergoing peritoneal dialysis with lactate- and bicarbonate-buffered peritoneal dialysis solutions.
Fourtounas C; Savidaki E; Roumelioti M; Dousdampanis P; Hardalias A; Kalliakmani P; Papachristou E; Drakopoulos A; Goumenos DS; Vlachojannis JG
Adv Perit Dial; 2006; 22():187-91. PubMed ID: 16983967
[TBL] [Abstract][Full Text] [Related]
18. The influence of bicarbonate/lactate-buffered PD fluids on N{ε}-(carboxyethyl)lysine and N{ε}-(carboxymethyl)lysine in peritoneal effluent.
Cnossen TT; Gladziwa U; van de Kerkhof JJ; Schalkwijk CG; Scheijen J; van Amersfoort J; Moret K; Beerenhout CH; Kooman JP
Perit Dial Int; 2011; 31(2):189-93. PubMed ID: 20671103
[TBL] [Abstract][Full Text] [Related]
19. Is introduction of the bicarbonate buffer in PD solution unavoidable?
Jörres A
Perit Dial Int; 1996; 16(5):444-5. PubMed ID: 8914173
[No Abstract] [Full Text] [Related]
20. Bicarbonate/lactate- and bicarbonate-buffered peritoneal dialysis fluids improve ex vivo peritoneal macrophage TNFalpha secretion.
MacKenzie RK; Holmes CJ; Moseley A; Jenkins JP; Williams JD; Coles GA; Faict D; Topley N
J Am Soc Nephrol; 1998 Aug; 9(8):1499-506. PubMed ID: 9697673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
